KLG Stock +78.58% In 3 Months Since We Picked It KLG Stock +78.58% In 3 Months Since We Picked It Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.71 Monday, 29th Apr 2024 CANF stock ended at $1.97. This is 0.505% less than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 2.68% from a day low at $1.97 to a day high of $2.02.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Sep 22, 2023 $2.56 $2.62 $2.52 $2.53 8 280
Sep 21, 2023 $2.70 $2.70 $2.70 $2.70 2 016
Sep 20, 2023 $2.65 $2.68 $2.65 $2.67 732
Sep 19, 2023 $2.69 $2.68 $2.54 $2.65 9 832
Sep 18, 2023 $2.69 $2.71 $2.63 $2.64 13 504
Sep 15, 2023 $2.76 $2.79 $2.66 $2.66 4 958
Sep 14, 2023 $2.69 $2.88 $2.63 $2.88 2 856
Sep 13, 2023 $2.83 $2.83 $2.60 $2.66 7 594
Sep 12, 2023 $2.90 $2.90 $2.79 $2.84 6 160
Sep 11, 2023 $2.82 $2.95 $2.81 $2.85 17 326
Sep 08, 2023 $2.76 $2.78 $2.76 $2.78 2 554
Sep 07, 2023 $2.81 $2.81 $2.79 $2.80 2 069
Sep 06, 2023 $2.83 $2.90 $2.77 $2.81 27 730
Sep 05, 2023 $2.90 $3.07 $2.91 $3.02 14 354
Sep 01, 2023 $2.88 $2.99 $2.86 $2.87 7 536
Aug 31, 2023 $2.83 $2.95 $2.75 $2.94 18 466
Aug 30, 2023 $2.80 $2.87 $2.80 $2.85 14 474
Aug 29, 2023 $2.75 $2.79 $2.74 $2.76 6 447
Aug 28, 2023 $2.65 $2.80 $2.65 $2.70 16 010
Aug 25, 2023 $2.64 $2.81 $2.64 $2.75 4 306
Aug 24, 2023 $2.60 $2.75 $2.57 $2.63 7 258
Aug 23, 2023 $2.55 $2.68 $2.52 $2.59 5 291
Aug 22, 2023 $2.65 $2.67 $2.54 $2.54 3 443
Aug 21, 2023 $2.62 $2.67 $2.57 $2.61 6 439
Aug 18, 2023 $2.58 $2.61 $2.51 $2.58 12 926
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT